Northern Trust’s Xtant Medical Holdings XTNT Stock Holding History

Northern Trust’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$42.6K	Buy	101,127 +1,529	+2%	+$734	﹤0.01%	4285
2026 Q1	$55.6K	Buy	99,598 +42,134	+73%	+$25.9K	﹤0.01%	4226
2025 Q4	$45.1K	Sell	57,464 -1,202	-2%	-$873	﹤0.01%	4300
2025 Q3	$38.1K	Hold	58,666	–	–	﹤0.01%	4317
2025 Q2	$43.4K	Hold	58,666	–	–	﹤0.01%	4254
2025 Q1	$27.6K	Hold	58,666	–	–	﹤0.01%	4303
2024 Q4	$26K	Hold	58,666	–	–	﹤0.01%	4354
2024 Q3	$39.7K	Hold	58,666	–	–	﹤0.01%	4248
2024 Q2	$37K	Hold	58,666	–	–	﹤0.01%	4253
2024 Q1	$68.6K	Hold	58,666	–	–	﹤0.01%	4172
2023 Q4	$66.3K	Buy	58,666 +16,257	+38%	+$19.1K	﹤0.01%	4183
2023 Q3	$46.6K	Buy	42,409 +21,348	+101%	+$22.9K	﹤0.01%	4185
2023 Q2	$19.6K	Hold	21,061	–	–	﹤0.01%	4414
2023 Q1	$13.4K	Hold	21,061	–	–	﹤0.01%	4494
2022 Q4	$13.9K	Buy	+21,061	New	+$13.8K	﹤0.01%	4540
2018 Q1	–	Sell	-213,239	Closed	-$1.47M	–	4285
2017 Q4	$1.47M	Buy	213,239 +212,133	+19,180%	+$1.67M	﹤0.01%	3280
2017 Q3	$10K	Buy	+1,106	New	+$9.89K	﹤0.01%	4205
2014 Q3	–	Sell	-327	Closed	-$27K	–	4363
2014 Q2	$27K	Hold	327	–	–	﹤0.01%	4161
2014 Q1	$33K	Hold	327	–	–	﹤0.01%	4087
2013 Q4	$20K	Hold	327	–	–	﹤0.01%	4037
2013 Q3	$26K	Hold	327	–	–	﹤0.01%	3982
2013 Q2	$18K	Buy	+327	New	+$27K	﹤0.01%	4010

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust's XTNT Position: Q2 2026 in Review

Northern Trust increased its Xtant Medical Holdings (XTNT) stake by 1.5% in Q2 2026, buying an estimated $734 and bringing the position to 101,127 shares worth $42.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4285.

Northern Trust first reported a position in XTNT in Q2 2013 and has held it in 22 quarters since. The position peaked at $1.47M in Q4 2017. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Northern Trust held 101,127 shares of Xtant Medical Holdings worth $42.6K as of Q2 2026.
Northern Trust bought 1,529 Xtant Medical Holdings shares in Q2 2026, an estimated $734.
Xtant Medical Holdings made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4285 holding.
Northern Trust first reported a position in Xtant Medical Holdings in Q2 2013 and has held it in 22 quarters since.
Northern Trust's Xtant Medical Holdings position peaked at $1.47M in Q4 2017.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.